Maven Securities’s Amicus Therapeutics FOLD Stock Holding History

Maven Securities’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,109,882	Closed	-$16M	–	377
2026 Q1	$16M	Buy	1,109,882 +320,600	+41%	+$4.6M	0.31%	74
2025 Q4	$11.2M	Buy	+789,282	New	+$7.75M	0.25%	98
2021 Q3	–	Sell	-64,422	Closed	-$634K	–	1127
2021 Q2	$634K	Buy	+64,422	New	+$629K	0.03%	572
2021 Q1	–	Sell	-51,704	Closed	-$1.2M	–	1211
2020 Q4	$1.2M	Buy	+51,704	New	+$1.06M	0.12%	210

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Maven Securities's FOLD Position: Q2 2026 in Review

Maven Securities sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 1,109,882 shares — an estimated $16M sold.

Maven Securities first reported a position in FOLD in Q4 2020 and held it in 4 quarters. The position peaked at $16M in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Maven Securities reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Maven Securities sold 1,109,882 Amicus Therapeutics shares in Q2 2026, an estimated $16M.
Maven Securities first reported a position in Amicus Therapeutics in Q4 2020 and held it in 4 quarters.
Maven Securities's Amicus Therapeutics position peaked at $16M in Q1 2026.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Maven Securities's 13F filing for Q2 2026, filed 14 Aug 2026.